IBDEI01L ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1529,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,1529,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,1530,0)
 ;;=R06.01^^8^119^18
 ;;^UTILITY(U,$J,358.3,1530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1530,1,3,0)
 ;;=3^Orthopnea
 ;;^UTILITY(U,$J,358.3,1530,1,4,0)
 ;;=4^R06.01
 ;;^UTILITY(U,$J,358.3,1530,2)
 ;;=^186737
 ;;^UTILITY(U,$J,358.3,1531,0)
 ;;=R06.81^^8^119^3
 ;;^UTILITY(U,$J,358.3,1531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1531,1,3,0)
 ;;=3^Apnea NEC
 ;;^UTILITY(U,$J,358.3,1531,1,4,0)
 ;;=4^R06.81
 ;;^UTILITY(U,$J,358.3,1531,2)
 ;;=^5019190
 ;;^UTILITY(U,$J,358.3,1532,0)
 ;;=R06.02^^8^119^22
 ;;^UTILITY(U,$J,358.3,1532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1532,1,3,0)
 ;;=3^Shortness of Breath
 ;;^UTILITY(U,$J,358.3,1532,1,4,0)
 ;;=4^R06.02
 ;;^UTILITY(U,$J,358.3,1532,2)
 ;;=^5019181
 ;;^UTILITY(U,$J,358.3,1533,0)
 ;;=R06.82^^8^119^25
 ;;^UTILITY(U,$J,358.3,1533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1533,1,3,0)
 ;;=3^Tachypnea NEC
 ;;^UTILITY(U,$J,358.3,1533,1,4,0)
 ;;=4^R06.82
 ;;^UTILITY(U,$J,358.3,1533,2)
 ;;=^5019191
 ;;^UTILITY(U,$J,358.3,1534,0)
 ;;=R94.30^^8^119^1
 ;;^UTILITY(U,$J,358.3,1534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1534,1,3,0)
 ;;=3^Abnormal Cardiovascular Function Study,Unspec
 ;;^UTILITY(U,$J,358.3,1534,1,4,0)
 ;;=4^R94.30
 ;;^UTILITY(U,$J,358.3,1534,2)
 ;;=^5019738
 ;;^UTILITY(U,$J,358.3,1535,0)
 ;;=R94.31^^8^119^2
 ;;^UTILITY(U,$J,358.3,1535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1535,1,3,0)
 ;;=3^Abnormal Electrocardiogram
 ;;^UTILITY(U,$J,358.3,1535,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,1535,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,1536,0)
 ;;=G90.9^^8^119^4
 ;;^UTILITY(U,$J,358.3,1536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1536,1,3,0)
 ;;=3^Autonomic Nervous System Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,1536,1,4,0)
 ;;=4^G90.9
 ;;^UTILITY(U,$J,358.3,1536,2)
 ;;=^5004173
 ;;^UTILITY(U,$J,358.3,1537,0)
 ;;=R56.00^^8^119^23
 ;;^UTILITY(U,$J,358.3,1537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1537,1,3,0)
 ;;=3^Simple Febrile Convulsions
 ;;^UTILITY(U,$J,358.3,1537,1,4,0)
 ;;=4^R56.00
 ;;^UTILITY(U,$J,358.3,1537,2)
 ;;=^5019522
 ;;^UTILITY(U,$J,358.3,1538,0)
 ;;=R56.9^^8^119^9
 ;;^UTILITY(U,$J,358.3,1538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1538,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,1538,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,1538,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,1539,0)
 ;;=R42.^^8^119^10
 ;;^UTILITY(U,$J,358.3,1539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1539,1,3,0)
 ;;=3^Dizziness and Giddiness
 ;;^UTILITY(U,$J,358.3,1539,1,4,0)
 ;;=4^R42.
 ;;^UTILITY(U,$J,358.3,1539,2)
 ;;=^5019450
 ;;^UTILITY(U,$J,358.3,1540,0)
 ;;=R50.81^^8^119^12
 ;;^UTILITY(U,$J,358.3,1540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1540,1,3,0)
 ;;=3^Fever in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,1540,1,4,0)
 ;;=4^R50.81
 ;;^UTILITY(U,$J,358.3,1540,2)
 ;;=^5019508
 ;;^UTILITY(U,$J,358.3,1541,0)
 ;;=R50.82^^8^119^20
 ;;^UTILITY(U,$J,358.3,1541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1541,1,3,0)
 ;;=3^Postprocedural Fever
 ;;^UTILITY(U,$J,358.3,1541,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,1541,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,1542,0)
 ;;=Z13.6^^8^119^21
 ;;^UTILITY(U,$J,358.3,1542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1542,1,3,0)
 ;;=3^Screening for Cardiovascular Disorders
 ;;^UTILITY(U,$J,358.3,1542,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,1542,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,1543,0)
 ;;=I25.2^^8^120^3
 ;;^UTILITY(U,$J,358.3,1543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1543,1,3,0)
 ;;=3^Old MI
 ;;^UTILITY(U,$J,358.3,1543,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,1543,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,1544,0)
 ;;=Z95.2^^8^120^6
 ;;^UTILITY(U,$J,358.3,1544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1544,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,1544,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,1544,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,1545,0)
 ;;=Z95.1^^8^120^4
 ;;^UTILITY(U,$J,358.3,1545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1545,1,3,0)
 ;;=3^Presence of Aortocoronary Bypass Graft
 ;;^UTILITY(U,$J,358.3,1545,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,1545,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,1546,0)
 ;;=Z98.61^^8^120^1
 ;;^UTILITY(U,$J,358.3,1546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1546,1,3,0)
 ;;=3^Coronary Angioplasty Status
 ;;^UTILITY(U,$J,358.3,1546,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,1546,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,1547,0)
 ;;=Z95.2^^8^120^7
 ;;^UTILITY(U,$J,358.3,1547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1547,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,1547,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,1547,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,1548,0)
 ;;=Z95.3^^8^120^8
 ;;^UTILITY(U,$J,358.3,1548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1548,1,3,0)
 ;;=3^Presence of Xenogenic Heart Valve
 ;;^UTILITY(U,$J,358.3,1548,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,1548,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,1549,0)
 ;;=Z95.4^^8^120^5
 ;;^UTILITY(U,$J,358.3,1549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1549,1,3,0)
 ;;=3^Presence of Heart Valve Replacement NEC
 ;;^UTILITY(U,$J,358.3,1549,1,4,0)
 ;;=4^Z95.4
 ;;^UTILITY(U,$J,358.3,1549,2)
 ;;=^5063672
 ;;^UTILITY(U,$J,358.3,1550,0)
 ;;=Z79.01^^8^120^2
 ;;^UTILITY(U,$J,358.3,1550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1550,1,3,0)
 ;;=3^Long Term Current Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,1550,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,1550,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,1551,0)
 ;;=I10.^^8^121^3
 ;;^UTILITY(U,$J,358.3,1551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1551,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,1551,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,1551,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,1552,0)
 ;;=I11.0^^8^121^6
 ;;^UTILITY(U,$J,358.3,1552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1552,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,1552,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,1552,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,1553,0)
 ;;=I11.9^^8^121^7
 ;;^UTILITY(U,$J,358.3,1553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1553,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,1553,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,1553,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,1554,0)
 ;;=I15.8^^8^121^5
 ;;^UTILITY(U,$J,358.3,1554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1554,1,3,0)
 ;;=3^Hypertension,Secondary
 ;;^UTILITY(U,$J,358.3,1554,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,1554,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,1555,0)
 ;;=I15.0^^8^121^4
 ;;^UTILITY(U,$J,358.3,1555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1555,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,1555,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,1555,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,1556,0)
 ;;=I70.1^^8^121^1
 ;;^UTILITY(U,$J,358.3,1556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1556,1,3,0)
 ;;=3^Atherosclerosis of Renal Artery
 ;;^UTILITY(U,$J,358.3,1556,1,4,0)
 ;;=4^I70.1
 ;;^UTILITY(U,$J,358.3,1556,2)
 ;;=^269760
 ;;^UTILITY(U,$J,358.3,1557,0)
 ;;=R03.0^^8^121^2
 ;;^UTILITY(U,$J,358.3,1557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1557,1,3,0)
 ;;=3^Elevated B/P Reading w/o HTN Diagnosis
 ;;^UTILITY(U,$J,358.3,1557,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,1557,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,1558,0)
 ;;=I95.1^^8^121^10
 ;;^UTILITY(U,$J,358.3,1558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1558,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,1558,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,1558,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,1559,0)
 ;;=I95.2^^8^121^8
 ;;^UTILITY(U,$J,358.3,1559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1559,1,3,0)
 ;;=3^Hypotension d/t Drugs
 ;;^UTILITY(U,$J,358.3,1559,1,4,0)
 ;;=4^I95.2
 ;;^UTILITY(U,$J,358.3,1559,2)
 ;;=^5008077
 ;;^UTILITY(U,$J,358.3,1560,0)
 ;;=I95.81^^8^121^11
 ;;^UTILITY(U,$J,358.3,1560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1560,1,3,0)
 ;;=3^Postprocedural Hypotension
 ;;^UTILITY(U,$J,358.3,1560,1,4,0)
 ;;=4^I95.81
 ;;^UTILITY(U,$J,358.3,1560,2)
 ;;=^5008078
 ;;^UTILITY(U,$J,358.3,1561,0)
 ;;=I95.9^^8^121^9
 ;;^UTILITY(U,$J,358.3,1561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1561,1,3,0)
 ;;=3^Hypotension,Unspec
 ;;^UTILITY(U,$J,358.3,1561,1,4,0)
 ;;=4^I95.9
 ;;^UTILITY(U,$J,358.3,1561,2)
 ;;=^5008080
 ;;^UTILITY(U,$J,358.3,1562,0)
 ;;=B25.9^^8^122^5
 ;;^UTILITY(U,$J,358.3,1562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1562,1,3,0)
 ;;=3^CMV Disease,Unspec
 ;;^UTILITY(U,$J,358.3,1562,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,1562,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,1563,0)
 ;;=I30.1^^8^122^7
 ;;^UTILITY(U,$J,358.3,1563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1563,1,3,0)
 ;;=3^Infective Pericarditis
 ;;^UTILITY(U,$J,358.3,1563,1,4,0)
 ;;=4^I30.1
 ;;^UTILITY(U,$J,358.3,1563,2)
 ;;=^5007158
 ;;^UTILITY(U,$J,358.3,1564,0)
 ;;=I30.0^^8^122^1
 ;;^UTILITY(U,$J,358.3,1564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1564,1,3,0)
 ;;=3^Acute Nonspecific Idiopathic Pericarditis
 ;;^UTILITY(U,$J,358.3,1564,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,1564,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,1565,0)
 ;;=I33.0^^8^122^3
 ;;^UTILITY(U,$J,358.3,1565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1565,1,3,0)
 ;;=3^Acute/Subacute Infective Endocarditis
 ;;^UTILITY(U,$J,358.3,1565,1,4,0)
 ;;=4^I33.0
 ;;^UTILITY(U,$J,358.3,1565,2)
 ;;=^5007167
 ;;^UTILITY(U,$J,358.3,1566,0)
 ;;=I33.9^^8^122^2
 ;;^UTILITY(U,$J,358.3,1566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1566,1,3,0)
 ;;=3^Acute/Subacute Endocarditis,Unspec
 ;;^UTILITY(U,$J,358.3,1566,1,4,0)
 ;;=4^I33.9
 ;;^UTILITY(U,$J,358.3,1566,2)
 ;;=^5007168
